MARLBOROUGH, Mass., November 1, 2017 — Hologic, Inc. (Nasdaq: HOLX) announced today that it will provide all mammography systems for the Dutch Breast Cancer Screening Program in partnership with Tromp Medical, Hologic's distributor in the Netherlands. Under the tender, Hologic's new, state-of-the-art 3DimensionsTM mammography systems will be installed in mobile and stationary screening facilities across the country, starting in 2018.
The multi-year agreement is the result of a comprehensive public procurement process conducted by Facilitaire Samenwerking Bevolkingsonderzoeken (FSB) on behalf of the five regional screening organizations responsible for nationwide breast screening in the Netherlands. The Dutch Breast Cancer Screening Program provides women between 50 and 75-years-old with a mammogram once every two years. Through the program, approximately 1.3 million women in the Netherlands are invited for screening each year.
"Hologic is grateful for the opportunity to extend access to its new, state-of-the-art 3DimensionsTM system to Dutch women starting in 2018," said Jan Verstreken, Hologic's Regional President for EMEA and Canada. "We were proud to learn that during the procurement process, the 3DimensionsTM system was ranked number one in ergonomics and patient comfort by clinicians and screening participants, and are hopeful that all Dutch women will take advantage of the invitation to get screened on this system."
KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs
FSB, on behalf of the five regional screening organizations, launched this public procurement process in 2016. A special prioritization was placed on finding new digital mammography systems that would improve the ergonomics of the screening experience for clinicians and the participating women. In addition to extensive testing among clinicians, a group of 30 participants in the screening program underwent tests on the equipment of all bidders. Both clinicians and participants ranked the 3DimensionsTM system number one in ergonomics and patient comfort.
In Europe, the 3DimensionsTM system is available in both 3D and 2D configurations. The 2D system is easily upgradeable to Hologic's 3DimensionsTM, which detects up to 65 percent more invasive breast cancers and is the only mammogram approved by the U.S. Food and Drug Administration as superior for women with dense breasts compared to 2D alone.[i],[ii]. It features Clarity HD high-resolution 3DTM imaging, which provides the industry's fastest, highest resolution 3DTM images to accelerate screening and analysis. The system is designed to clearly reveal subtle lesions and fine calcifications to help pinpoint cancers early. Designed to increase clinical confidence and achieve more accuracy the first time, Clarity HD reduces recalls by up to 40 percent compared to 2D alone.[iii],[iv],[v],[vi] In addition, the 3DimensionsTM system offers Intelligent 2DTM imaging technology, which works with Clarity HD technology to deliver unprecedented clarity, contrast and detail at a lower dose, and the QuantraTM 2.2 breast density assessment software, which enables standardization in patient protocols, providing reproducible and consistent breast density assessment.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
About Tromp Medical
Tromp Medical B.V. is a highly skilled distributor of advanced medical imaging equipment, successfully distributing Hologic's imaging products in The Netherlands for almost two decades. For more information on Tromp Medical, visit www.trompmedical.com.